Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
Eiman Alzaabi, President of the Transfusion Working Group under the Emirates Medical Association and Medical Director of the SEHA Blood Bank, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
”Scientific progress depends on those who choose to share rare observations and challenge assumptions.
Proud to contribute to the transfusion medicine community with this work—and deeply grateful to an outstanding team whose expertise, persistence, and collaboration made it possible. This is what collective science looks like.”
Title: Anti-Ku alloimmunization due to a KEL*02N.19 allele causing Kell-null phenotype despite KEL*02 genotype prediction
Authors: Ravi C. Dara, Rania Madkour, Kathleen Bensing, Eiman Alzaabi, Ihsanullah Sadiq, Nyaradzo Chada, Ghada H. Mawad, Kathleen E. Puca, Manuel Algora
Read the Full Article on Vox Sanguinis.
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage
-
Oct 9, 2026, 13:07The Rebalanced Patient: New Therapies and New Thrombotic Risks in Hemophilia